Table of Content

1 Anthrax Vaccines Market Overview
1.1 Anthrax Vaccines Product Overview
1.2 Anthrax Vaccines Market Segment by Type
1.2.1 Live Vaccines
1.2.2 Cell free PA Vaccines
1.3 Global Anthrax Vaccines Market Size by Type
1.3.1 Global Anthrax Vaccines Market Size Overview by Type (2018-2034)
1.3.2 Global Anthrax Vaccines Historic Market Size Review by Type (2018-2024)
1.3.3 Global Anthrax Vaccines Forecasted Market Size by Type (2024-2034)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Anthrax Vaccines Sales Breakdown by Type (2018-2024)
1.4.2 Europe Anthrax Vaccines Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Anthrax Vaccines Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Anthrax Vaccines Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Anthrax Vaccines Sales Breakdown by Type (2018-2024)
2 Global Anthrax Vaccines Market Competition by Company
2.1 Global Top Players by Anthrax Vaccines Sales (2018-2024)
2.2 Global Top Players by Anthrax Vaccines Revenue (2018-2024)
2.3 Global Top Players by Anthrax Vaccines Price (2018-2024)
2.4 Global Top Manufacturers Anthrax Vaccines Manufacturing Base Distribution, Sales Area, Product Type
2.5 Anthrax Vaccines Market Competitive Situation and Trends
2.5.1 Anthrax Vaccines Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Anthrax Vaccines Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Anthrax Vaccines as of 2022)
2.7 Date of Key Manufacturers Enter into Anthrax Vaccines Market
2.8 Key Manufacturers Anthrax Vaccines Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Anthrax Vaccines Status and Outlook by Region
3.1 Global Anthrax Vaccines Market Size and CAGR by Region: 2018 VS 2022 VS 2034
3.2 Global Anthrax Vaccines Historic Market Size by Region
3.2.1 Global Anthrax Vaccines Sales in Volume by Region (2018-2024)
3.2.2 Global Anthrax Vaccines Sales in Value by Region (2018-2024)
3.2.3 Global Anthrax Vaccines Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Anthrax Vaccines Forecasted Market Size by Region
3.3.1 Global Anthrax Vaccines Sales in Volume by Region (2024-2034)
3.3.2 Global Anthrax Vaccines Sales in Value by Region (2024-2034)
3.3.3 Global Anthrax Vaccines Sales (Volume & Value), Price and Gross Margin (2024-2034)
4 Global Anthrax Vaccines by Application
4.1 Anthrax Vaccines Market Segment by Application
4.1.1 Human Use
4.1.2 Animal Use
4.2 Global Anthrax Vaccines Market Size by Application
4.2.1 Global Anthrax Vaccines Market Size Overview by Application (2018-2034)
4.2.2 Global Anthrax Vaccines Historic Market Size Review by Application (2018-2024)
4.2.3 Global Anthrax Vaccines Forecasted Market Size by Application (2024-2034)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Anthrax Vaccines Sales Breakdown by Application (2018-2024)
4.3.2 Europe Anthrax Vaccines Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Anthrax Vaccines Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Anthrax Vaccines Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Anthrax Vaccines Sales Breakdown by Application (2018-2024)
5 North America Anthrax Vaccines by Country
5.1 North America Anthrax Vaccines Historic Market Size by Country
5.1.1 North America Anthrax Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
5.1.2 North America Anthrax Vaccines Sales in Volume by Country (2018-2024)
5.1.3 North America Anthrax Vaccines Sales in Value by Country (2018-2024)
5.2 North America Anthrax Vaccines Forecasted Market Size by Country
5.2.1 North America Anthrax Vaccines Sales in Volume by Country (2024-2034)
5.2.2 North America Anthrax Vaccines Sales in Value by Country (2024-2034)
6 Europe Anthrax Vaccines by Country
6.1 Europe Anthrax Vaccines Historic Market Size by Country
6.1.1 Europe Anthrax Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
6.1.2 Europe Anthrax Vaccines Sales in Volume by Country (2018-2024)
6.1.3 Europe Anthrax Vaccines Sales in Value by Country (2018-2024)
6.2 Europe Anthrax Vaccines Forecasted Market Size by Country
6.2.1 Europe Anthrax Vaccines Sales in Volume by Country (2024-2034)
6.2.2 Europe Anthrax Vaccines Sales in Value by Country (2024-2034)
7 Asia-Pacific Anthrax Vaccines by Region
7.1 Asia-Pacific Anthrax Vaccines Historic Market Size by Region
7.1.1 Asia-Pacific Anthrax Vaccines Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2034
7.1.2 Asia-Pacific Anthrax Vaccines Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Anthrax Vaccines Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Anthrax Vaccines Forecasted Market Size by Region
7.2.1 Asia-Pacific Anthrax Vaccines Sales in Volume by Region (2024-2034)
7.2.2 Asia-Pacific Anthrax Vaccines Sales in Value by Region (2024-2034)
8 Latin America Anthrax Vaccines by Country
8.1 Latin America Anthrax Vaccines Historic Market Size by Country
8.1.1 Latin America Anthrax Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
8.1.2 Latin America Anthrax Vaccines Sales in Volume by Country (2018-2024)
8.1.3 Latin America Anthrax Vaccines Sales in Value by Country (2018-2024)
8.2 Latin America Anthrax Vaccines Forecasted Market Size by Country
8.2.1 Latin America Anthrax Vaccines Sales in Volume by Country (2024-2034)
8.2.2 Latin America Anthrax Vaccines Sales in Value by Country (2024-2034)
9 Middle East and Africa Anthrax Vaccines by Country
9.1 Middle East and Africa Anthrax Vaccines Historic Market Size by Country
9.1.1 Middle East and Africa Anthrax Vaccines Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2034
9.1.2 Middle East and Africa Anthrax Vaccines Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Anthrax Vaccines Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Anthrax Vaccines Forecasted Market Size by Country
9.2.1 Middle East and Africa Anthrax Vaccines Sales in Volume by Country (2024-2034)
9.2.2 Middle East and Africa Anthrax Vaccines Sales in Value by Country (2024-2034)
10 Company Profiles
10.1 Emergent BioSolutions
10.1.1 Emergent BioSolutions Company Information
10.1.2 Emergent BioSolutions Introduction and Business Overview
10.1.3 Emergent BioSolutions Anthrax Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Emergent BioSolutions Anthrax Vaccines Products Offered
10.1.5 Emergent BioSolutions Recent Development
10.2 Merial
10.2.1 Merial Company Information
10.2.2 Merial Introduction and Business Overview
10.2.3 Merial Anthrax Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Merial Anthrax Vaccines Products Offered
10.2.5 Merial Recent Development
10.3 Merck
10.3.1 Merck Company Information
10.3.2 Merck Introduction and Business Overview
10.3.3 Merck Anthrax Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Merck Anthrax Vaccines Products Offered
10.3.5 Merck Recent Development
10.4 Zoetis
10.4.1 Zoetis Company Information
10.4.2 Zoetis Introduction and Business Overview
10.4.3 Zoetis Anthrax Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Zoetis Anthrax Vaccines Products Offered
10.4.5 Zoetis Recent Development
10.5 Bayer Sanidad Animal
10.5.1 Bayer Sanidad Animal Company Information
10.5.2 Bayer Sanidad Animal Introduction and Business Overview
10.5.3 Bayer Sanidad Animal Anthrax Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Bayer Sanidad Animal Anthrax Vaccines Products Offered
10.5.5 Bayer Sanidad Animal Recent Development
10.6 Colorado Serum
10.6.1 Colorado Serum Company Information
10.6.2 Colorado Serum Introduction and Business Overview
10.6.3 Colorado Serum Anthrax Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Colorado Serum Anthrax Vaccines Products Offered
10.6.5 Colorado Serum Recent Development
10.7 PharmAthene
10.7.1 PharmAthene Company Information
10.7.2 PharmAthene Introduction and Business Overview
10.7.3 PharmAthene Anthrax Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.7.4 PharmAthene Anthrax Vaccines Products Offered
10.7.5 PharmAthene Recent Development
10.8 Tiankang
10.8.1 Tiankang Company Information
10.8.2 Tiankang Introduction and Business Overview
10.8.3 Tiankang Anthrax Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Tiankang Anthrax Vaccines Products Offered
10.8.5 Tiankang Recent Development
10.9 Biogénesis-Bago
10.9.1 Biogénesis-Bago Company Information
10.9.2 Biogénesis-Bago Introduction and Business Overview
10.9.3 Biogénesis-Bago Anthrax Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Biogénesis-Bago Anthrax Vaccines Products Offered
10.9.5 Biogénesis-Bago Recent Development
10.10 CAVAC
10.10.1 CAVAC Company Information
10.10.2 CAVAC Introduction and Business Overview
10.10.3 CAVAC Anthrax Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.10.4 CAVAC Anthrax Vaccines Products Offered
10.10.5 CAVAC Recent Development
10.11 Rosenbusch
10.11.1 Rosenbusch Company Information
10.11.2 Rosenbusch Introduction and Business Overview
10.11.3 Rosenbusch Anthrax Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Rosenbusch Anthrax Vaccines Products Offered
10.11.5 Rosenbusch Recent Development
10.12 Agrovet
10.12.1 Agrovet Company Information
10.12.2 Agrovet Introduction and Business Overview
10.12.3 Agrovet Anthrax Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.12.4 Agrovet Anthrax Vaccines Products Offered
10.12.5 Agrovet Recent Development
10.13 Vecol
10.13.1 Vecol Company Information
10.13.2 Vecol Introduction and Business Overview
10.13.3 Vecol Anthrax Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.13.4 Vecol Anthrax Vaccines Products Offered
10.13.5 Vecol Recent Development
10.14 CVCRI
10.14.1 CVCRI Company Information
10.14.2 CVCRI Introduction and Business Overview
10.14.3 CVCRI Anthrax Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.14.4 CVCRI Anthrax Vaccines Products Offered
10.14.5 CVCRI Recent Development
10.15 IVPM
10.15.1 IVPM Company Information
10.15.2 IVPM Introduction and Business Overview
10.15.3 IVPM Anthrax Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.15.4 IVPM Anthrax Vaccines Products Offered
10.15.5 IVPM Recent Development
10.16 Prondil
10.16.1 Prondil Company Information
10.16.2 Prondil Introduction and Business Overview
10.16.3 Prondil Anthrax Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.16.4 Prondil Anthrax Vaccines Products Offered
10.16.5 Prondil Recent Development
10.17 CDV
10.17.1 CDV Company Information
10.17.2 CDV Introduction and Business Overview
10.17.3 CDV Anthrax Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.17.4 CDV Anthrax Vaccines Products Offered
10.17.5 CDV Recent Development
10.18 Indian Immunologicals
10.18.1 Indian Immunologicals Company Information
10.18.2 Indian Immunologicals Introduction and Business Overview
10.18.3 Indian Immunologicals Anthrax Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.18.4 Indian Immunologicals Anthrax Vaccines Products Offered
10.18.5 Indian Immunologicals Recent Development
10.19 Botswana Vaccine Institute
10.19.1 Botswana Vaccine Institute Company Information
10.19.2 Botswana Vaccine Institute Introduction and Business Overview
10.19.3 Botswana Vaccine Institute Anthrax Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.19.4 Botswana Vaccine Institute Anthrax Vaccines Products Offered
10.19.5 Botswana Vaccine Institute Recent Development
10.20 Ceva Santé Animale
10.20.1 Ceva Santé Animale Company Information
10.20.2 Ceva Santé Animale Introduction and Business Overview
10.20.3 Ceva Santé Animale Anthrax Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.20.4 Ceva Santé Animale Anthrax Vaccines Products Offered
10.20.5 Ceva Santé Animale Recent Development
10.21 Intervac
10.21.1 Intervac Company Information
10.21.2 Intervac Introduction and Business Overview
10.21.3 Intervac Anthrax Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.21.4 Intervac Anthrax Vaccines Products Offered
10.21.5 Intervac Recent Development
10.22 JOVAC
10.22.1 JOVAC Company Information
10.22.2 JOVAC Introduction and Business Overview
10.22.3 JOVAC Anthrax Vaccines Sales, Revenue and Gross Margin (2018-2024)
10.22.4 JOVAC Anthrax Vaccines Products Offered
10.22.5 JOVAC Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Anthrax Vaccines Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Anthrax Vaccines Industrial Chain Analysis
11.4 Anthrax Vaccines Market Dynamics
11.4.1 Anthrax Vaccines Industry Trends
11.4.2 Anthrax Vaccines Market Drivers
11.4.3 Anthrax Vaccines Market Challenges
11.4.4 Anthrax Vaccines Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Anthrax Vaccines Distributors
12.3 Anthrax Vaccines Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Live Vaccines
Table 2. Major Company of Cell free PA Vaccines
Table 3. Global Anthrax Vaccines Sales by Type 2018 VS 2022 VS 2034 (US$ Million)
Table 4. Global Anthrax Vaccines Sales by Type (2018-2024) & (M Doses)
Table 5. Global Anthrax Vaccines Sales Market Share in Volume by Type (2018-2024)
Table 6. Global Anthrax Vaccines Sales by Type (2018-2024) & (US& Million)
Table 7. Global Anthrax Vaccines Market Share in Value by Type (2018-2024)
Table 8. Global Anthrax Vaccines Price by Type (2018-2024) & (USD/Dose)
Table 9. Global Anthrax Vaccines Sales by Type (2024-2034) & (M Doses)
Table 10. Global Anthrax Vaccines Sales Market Share in Volume by Type (2024-2034)
Table 11. Global Anthrax Vaccines Sales by Type (2024-2034) & (US$ Million)
Table 12. Global Anthrax Vaccines Sales Market Share in Value by Type (2024-2034)
Table 13. Global Anthrax Vaccines Price by Type (2024-2034) & (USD/Dose)
Table 14. North America Anthrax Vaccines Sales by Type (2018-2024) & (M Doses)
Table 15. North America Anthrax Vaccines Sales by Type (2018-2024) & (US$ Million)
Table 16. Europe Anthrax Vaccines Sales (M Doses) by Type (2018-2024)
Table 17. Europe Anthrax Vaccines Sales by Type (2018-2024) & (US$ Million)
Table 18. Asia-Pacific Anthrax Vaccines Sales (M Doses) by Type (2018-2024)
Table 19. Asia-Pacific Anthrax Vaccines Sales by Type (2018-2024) & (US$ Million)
Table 20. Latin America Anthrax Vaccines Sales (M Doses) by Type (2018-2024)
Table 21. Latin America Anthrax Vaccines Sales by Type (2018-2024) & (US$ Million)
Table 22. Middle East and Africa Anthrax Vaccines Sales (M Doses) by Type (2018-2024)
Table 23. Middle East and Africa Anthrax Vaccines Sales by Type (2018-2024) & (US$ Million)
Table 24. Global Anthrax Vaccines Sales by Company (2018-2024) & (M Doses)
Table 25. Global Anthrax Vaccines Sales Share by Company (2018-2024)
Table 26. Global Anthrax Vaccines Revenue by Company (2018-2024) & (US$ Million)
Table 27. Global Anthrax Vaccines Revenue Share by Company (2018-2024)
Table 28. Global Market Anthrax Vaccines Price by Company (2018-2024) & (USD/Dose)
Table 29. Global Anthrax Vaccines Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Anthrax Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Anthrax Vaccines as of 2022)
Table 32. Date of Key Manufacturers Enter into Anthrax Vaccines Market
Table 33. Key Manufacturers Anthrax Vaccines Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Anthrax Vaccines Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2034
Table 36. Global Anthrax Vaccines Sales by Region (2018-2024) & (M Doses)
Table 37. Global Anthrax Vaccines Sales Market Share in Volume by Region (2018-2024)
Table 38. Global Anthrax Vaccines Sales by Region (2018-2024) & (US$ Million)
Table 39. Global Anthrax Vaccines Sales Market Share in Value by Region (2018-2024)
Table 40. Global Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2018-2024)
Table 41. Global Anthrax Vaccines Sales by Region (2024-2034) & (M Doses)
Table 42. Global Anthrax Vaccines Sales Market Share in Volume by Region (2024-2034)
Table 43. Global Anthrax Vaccines Sales by Region (2024-2034) & (US$ Million)
Table 44. Global Anthrax Vaccines Sales Market Share in Value by Region (2024-2034)
Table 45. Global Anthrax Vaccines Sales (M Doses), Revenue (US$ Million), Price (USD/Dose) and Gross Margin (2024-2034)
Table 46. Global Anthrax Vaccines Sales by Application: 2018 VS 2022 VS 2034 (US$ Million)
Table 47. Global Anthrax Vaccines Sales by Application (2018-2024) & (M Doses)
Table 48. Global Anthrax Vaccines Sales Market Share in Volume by Application (2018-2024)
Table 49. Global Anthrax Vaccines Sales by Application (2018-2024) & (US$ Million)
Table 50. Global Anthrax Vaccines Sales Market Share in Value by Application (2018-2024)
Table 51. Global Anthrax Vaccines Price by Application (2018-2024) & (USD/Dose)
Table 52. Global Anthrax Vaccines Sales by Application (2024-2034) & (M Doses)
Table 53. Global Anthrax Vaccines Sales Market Share in Volume by Application (2024-2034)
Table 54. Global Anthrax Vaccines Sales by Application (2024-2034) & (US$ Million)
Table 55. Global Anthrax Vaccines Sales Market Share in Value by Application (2024-2034)
Table 56. Global Anthrax Vaccines Price by Application (2024-2034) & (USD/Dose)
Table 57. North America Anthrax Vaccines Sales by Application (2018-2024) (M Doses)
Table 58. North America Anthrax Vaccines Sales by Application (2018-2024) & (US$ Million)
Table 59. Europe Anthrax Vaccines Sales by Application (2018-2024) (M Doses)
Table 60. Europe Anthrax Vaccines Sales by Application (2018-2024) & (US$ Million)
Table 61. Asia-Pacific Anthrax Vaccines Sales by Application (2018-2024) (M Doses)
Table 62. Asia-Pacific Anthrax Vaccines Sales by Application (2018-2024) & (US$ Million)
Table 63. Latin America Anthrax Vaccines Sales by Application (2018-2024) (M Doses)
Table 64. Latin America Anthrax Vaccines Sales by Application (2018-2024) & (US$ Million)
Table 65. Middle East and Africa Anthrax Vaccines Sales by Application (2018-2024) (M Doses)
Table 66. Middle East and Africa Anthrax Vaccines Sales by Application (2018-2024) & (US$ Million)
Table 67. North America Anthrax Vaccines Sales by Country (2018-2024) & (M Doses)
Table 68. North America Anthrax Vaccines Sales Market Share in Volume by Country (2018-2024)
Table 69. North America Anthrax Vaccines Sales by Country (2018-2024) & (US$ Million)
Table 70. North America Anthrax Vaccines Sales Market Share in Value by Country (2018-2024)
Table 71. North America Anthrax Vaccines Sales by Country (2024-2034) & (M Doses)
Table 72. North America Anthrax Vaccines Sales Market Share in Volume by Country (2024-2034)
Table 73. North America Anthrax Vaccines Sales by Country (2024-2034) & (US$ Million)
Table 74. North America Anthrax Vaccines Sales Market Share in Value by Country (2024-2034)
Table 75. Europe Anthrax Vaccines Sales by Country (2018-2024) & (M Doses)
Table 76. Europe Anthrax Vaccines Sales Market Share in Volume by Country (2018-2024)
Table 77. Europe Anthrax Vaccines Sales by Country (2018-2024) & (US$ Million)
Table 78. Europe Anthrax Vaccines Sales Market Share in Value by Country (2018-2024)
Table 79. Europe Anthrax Vaccines Sales by Country (2024-2034) & (M Doses)
Table 80. Europe Anthrax Vaccines Sales Market Share in Volume by Country (2024-2034)
Table 81. Europe Anthrax Vaccines Sales by Country (2024-2034) & (US$ Million)
Table 82. Europe Anthrax Vaccines Sales Market Share in Value by Country (2024-2034)
Table 83. Asia-Pacific Anthrax Vaccines Sales by Region (2018-2024) & (M Doses)
Table 84. Asia-Pacific Anthrax Vaccines Sales Market Share in Volume by Region (2018-2024)
Table 85. Asia-Pacific Anthrax Vaccines Sales by Region (2018-2024) & (US$ Million)
Table 86. Asia-Pacific Anthrax Vaccines Sales Market Share in Value by Region (2018-2024)
Table 87. Asia-Pacific Anthrax Vaccines Sales by Region (2024-2034) & (M Doses)
Table 88. Asia-Pacific Anthrax Vaccines Sales Market Share in Volume by Region (2024-2034)
Table 89. Asia-Pacific Anthrax Vaccines Sales by Region (2024-2034) & (US$ Million)
Table 90. Asia-Pacific Anthrax Vaccines Sales Market Share in Value by Region (2024-2034)
Table 91. Latin America Anthrax Vaccines Sales by Country (2018-2024) & (M Doses)
Table 92. Latin America Anthrax Vaccines Sales Market Share in Volume by Country (2018-2024)
Table 93. Latin America Anthrax Vaccines Sales by Country (2018-2024) & (US$ Million)
Table 94. Latin America Anthrax Vaccines Sales Market Share in Value by Country (2018-2024)
Table 95. Latin America Anthrax Vaccines Sales by Country (2024-2034) & (M Doses)
Table 96. Latin America Anthrax Vaccines Sales Market Share in Volume by Country (2024-2034)
Table 97. Latin America Anthrax Vaccines Sales by Country (2024-2034) & (US$ Million)
Table 98. Latin America Anthrax Vaccines Sales Market Share in Value by Country (2024-2034)
Table 99. Middle East and Africa Anthrax Vaccines Sales by Country (2018-2024) & (M Doses)
Table 100. Middle East and Africa Anthrax Vaccines Sales Market Share in Volume by Country (2018-2024)
Table 101. Middle East and Africa Anthrax Vaccines Sales by Country (2018-2024) & (US$ Million)
Table 102. Middle East and Africa Anthrax Vaccines Sales Market Share in Value by Country (2018-2024)
Table 103. Middle East and Africa Anthrax Vaccines Sales by Country (2024-2034) & (M Doses)
Table 104. Middle East and Africa Anthrax Vaccines Sales Market Share in Volume by Country (2024-2034)
Table 105. Middle East and Africa Anthrax Vaccines Sales by Country (2024-2034) & (US$ Million)
Table 106. Middle East and Africa Anthrax Vaccines Sales Market Share in Value by Country (2024-2034)
Table 107. Emergent BioSolutions Company Information
Table 108. Emergent BioSolutions Introduction and Business Overview
Table 109. Emergent BioSolutions Anthrax Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 110. Emergent BioSolutions Anthrax Vaccines Product
Table 111. Emergent BioSolutions Recent Development
Table 112. Merial Company Information
Table 113. Merial Introduction and Business Overview
Table 114. Merial Anthrax Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 115. Merial Anthrax Vaccines Product
Table 116. Merial Recent Development
Table 117. Merck Company Information
Table 118. Merck Introduction and Business Overview
Table 119. Merck Anthrax Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 120. Merck Anthrax Vaccines Product
Table 121. Merck Recent Development
Table 122. Zoetis Company Information
Table 123. Zoetis Introduction and Business Overview
Table 124. Zoetis Anthrax Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 125. Zoetis Anthrax Vaccines Product
Table 126. Zoetis Recent Development
Table 127. Bayer Sanidad Animal Company Information
Table 128. Bayer Sanidad Animal Introduction and Business Overview
Table 129. Bayer Sanidad Animal Anthrax Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 130. Bayer Sanidad Animal Anthrax Vaccines Product
Table 131. Bayer Sanidad Animal Recent Development
Table 132. Colorado Serum Company Information
Table 133. Colorado Serum Introduction and Business Overview
Table 134. Colorado Serum Anthrax Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 135. Colorado Serum Anthrax Vaccines Product
Table 136. Colorado Serum Recent Development
Table 137. PharmAthene Company Information
Table 138. PharmAthene Introduction and Business Overview
Table 139. PharmAthene Anthrax Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 140. PharmAthene Anthrax Vaccines Product
Table 141. PharmAthene Recent Development
Table 142. Tiankang Company Information
Table 143. Tiankang Introduction and Business Overview
Table 144. Tiankang Anthrax Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 145. Tiankang Anthrax Vaccines Product
Table 146. Tiankang Recent Development
Table 147. Biogénesis-Bago Company Information
Table 148. Biogénesis-Bago Introduction and Business Overview
Table 149. Biogénesis-Bago Anthrax Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 150. Biogénesis-Bago Anthrax Vaccines Product
Table 151. Biogénesis-Bago Recent Development
Table 152. CAVAC Company Information
Table 153. CAVAC Introduction and Business Overview
Table 154. CAVAC Anthrax Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 155. CAVAC Anthrax Vaccines Product
Table 156. CAVAC Recent Development
Table 157. Rosenbusch Company Information
Table 158. Rosenbusch Introduction and Business Overview
Table 159. Rosenbusch Anthrax Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 160. Rosenbusch Anthrax Vaccines Product
Table 161. Rosenbusch Recent Development
Table 162. Agrovet Company Information
Table 163. Agrovet Introduction and Business Overview
Table 164. Agrovet Anthrax Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 165. Agrovet Anthrax Vaccines Product
Table 166. Agrovet Recent Development
Table 167. Vecol Company Information
Table 168. Vecol Introduction and Business Overview
Table 169. Vecol Anthrax Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 170. Vecol Anthrax Vaccines Product
Table 171. Vecol Recent Development
Table 172. CVCRI Company Information
Table 173. CVCRI Introduction and Business Overview
Table 174. CVCRI Anthrax Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 175. CVCRI Anthrax Vaccines Product
Table 176. CVCRI Recent Development
Table 177. IVPM Company Information
Table 178. IVPM Introduction and Business Overview
Table 179. IVPM Anthrax Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 180. IVPM Anthrax Vaccines Product
Table 181. IVPM Recent Development
Table 182. Prondil Company Information
Table 183. Prondil Introduction and Business Overview
Table 184. Prondil Anthrax Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 185. Prondil Anthrax Vaccines Product
Table 186. Prondil Recent Development
Table 187. CDV Company Information
Table 188. CDV Introduction and Business Overview
Table 189. CDV Anthrax Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 190. CDV Anthrax Vaccines Product
Table 191. CDV Recent Development
Table 192. Indian Immunologicals Company Information
Table 193. Indian Immunologicals Introduction and Business Overview
Table 194. Indian Immunologicals Anthrax Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 195. Indian Immunologicals Anthrax Vaccines Product
Table 196. Indian Immunologicals Recent Development
Table 197. Botswana Vaccine Institute Company Information
Table 198. Botswana Vaccine Institute Introduction and Business Overview
Table 199. Botswana Vaccine Institute Anthrax Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 200. Botswana Vaccine Institute Anthrax Vaccines Product
Table 201. Botswana Vaccine Institute Recent Development
Table 202. Ceva Santé Animale Company Information
Table 203. Ceva Santé Animale Introduction and Business Overview
Table 204. Ceva Santé Animale Anthrax Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 205. Ceva Santé Animale Anthrax Vaccines Product
Table 206. Ceva Santé Animale Recent Development
Table 207. Intervac Company Information
Table 208. Intervac Introduction and Business Overview
Table 209. Intervac Anthrax Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 210. Intervac Anthrax Vaccines Product
Table 211. Intervac Recent Development
Table 212. JOVAC Company Information
Table 213. JOVAC Introduction and Business Overview
Table 214. JOVAC Anthrax Vaccines Sales (M Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2018-2024)
Table 215. JOVAC Anthrax Vaccines Product
Table 216. JOVAC Recent Development
Table 217. Key Raw Materials Lists
Table 218. Raw Materials Key Suppliers Lists
Table 219. Anthrax Vaccines Market Trends
Table 220. Anthrax Vaccines Market Drivers
Table 221. Anthrax Vaccines Market Challenges
Table 222. Anthrax Vaccines Market Restraints
Table 223. Anthrax Vaccines Distributors List
Table 224. Anthrax Vaccines Downstream Customers
Table 225. Research Programs/Design for This Report
Table 226. Key Data Information from Secondary Sources
Table 227. Key Data Information from Primary Sources
List of Figures
Figure 1. Anthrax Vaccines Product Picture
Figure 2. Global Anthrax Vaccines Market Size, 2018 VS 2022 VS 2034 (US$ Million)
Figure 3. Global Anthrax Vaccines Market Size Status and Outlook (2018-2034) & (US$ Million)
Figure 4. Global Anthrax Vaccines Sales Status and Outlook (2018-2034) & (M Doses)
Figure 5. Product Picture of Live Vaccines
Figure 6. Global Live Vaccines Sales YoY Growth (2018-2034) & (M Doses)
Figure 7. Product Picture of Cell free PA Vaccines
Figure 8. Global Cell free PA Vaccines Sales YoY Growth (2018-2034) & (M Doses)
Figure 9. Global Anthrax Vaccines Sales by Type (2018-2034) & (US$ Million)
Figure 10. Global Anthrax Vaccines Sales Market Share by Type in 2022 & 2034
Figure 11. North America Anthrax Vaccines Sales Market Share in Volume by Type in 2022
Figure 12. North America Anthrax Vaccines Sales Market Share in Value by Type in 2022
Figure 13. Europe Anthrax Vaccines Sales Market Share in Volume by Type in 2022
Figure 14. Europe Anthrax Vaccines Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Anthrax Vaccines Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Anthrax Vaccines Sales Market Share in Value by Type in 2022
Figure 17. Latin America Anthrax Vaccines Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Anthrax Vaccines Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Anthrax Vaccines Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Anthrax Vaccines Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Anthrax Vaccines Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Anthrax Vaccines Revenue in 2022
Figure 23. Anthrax Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 24. Product Picture of Human Use
Figure 25. Global Human Use Sales YoY Growth (2018-2034) & (M Doses)
Figure 26. Product Picture of Animal Use
Figure 27. Global Animal Use Sales YoY Growth (2018-2034) & (M Doses)
Figure 28. Global Anthrax Vaccines Sales by Application (2018-2034) & (US$ Million)
Figure 29. Global Anthrax Vaccines Sales Market Share by Application in 2022 & 2034
Figure 30. North America Anthrax Vaccines Sales Market Share in Volume by Application in 2022
Figure 31. North America Anthrax Vaccines Sales Market Share in Value by Application in 2022
Figure 32. Europe Anthrax Vaccines Sales Market Share in Volume by Application in 2022
Figure 33. Europe Anthrax Vaccines Sales Market Share in Value by Application in 2022
Figure 34. Asia-Pacific Anthrax Vaccines Sales Market Share in Volume by Application in 2022
Figure 35. Asia-Pacific Anthrax Vaccines Sales Market Share in Value by Application in 2022
Figure 36. Latin America Anthrax Vaccines Sales Market Share in Volume by Application in 2022
Figure 37. Latin America Anthrax Vaccines Sales Market Share in Value by Application in 2022
Figure 38. Middle East and Africa Anthrax Vaccines Sales Market Share in Value by Application in 2022
Figure 39. Key Raw Materials Price
Figure 40. Anthrax Vaccines Manufacturing Cost Structure
Figure 41. Anthrax Vaccines Industrial Chain Analysis
Figure 42. Channels of Distribution
Figure 43. Distributors Profiles
Figure 44. Bottom-up and Top-down Approaches for This Report
Figure 45. Data Triangulation
Figure 46. Key Executives Interviewed